Agilent Technologies Inc operates within the healthcare sector, specifically in diagnostics and research, with a market capitalization of approximately $36.5 billion. The company's fundamentals reflect a trailing P/E ratio of 30.15 and a forward P/E of 21.28, indicating a premium valuation relative to earnings. The price-to-sales ratio stands at 5.38, while the price-to-book ratio is 5.73. Agilent's return on equity is robust at 19.9%, and it maintains a profit margin of 18% alongside an operating margin of 23.2%. Year-over-year changes show a 21.6% increase in quarterly earnings and a 10.1% rise in quarterly revenue, suggesting solid growth momentum. From a technical perspective, Agilent's stock closed at $128.78, reflecting a daily increase of 0.21% and a weekly gain of 3.03%. The stock is trading above its 50-day and 200-day moving averages, indicating a bullish trend. It is currently near its 52-week high, which is approximately 15.93% away, and the average trading volume over the past 20 days is 1,604,290 shares, with a volume ratio of 1.02, suggesting healthy trading activity. Insider ownership is relatively low at 29%, while institutional ownership is high at 92